Skip to content

Revvity RVTY Effect of exchange rate changes on cash, cash equivalents and restricted cash

Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies

Veeva Systems logo
Veeva SystemsVEEV
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Zoetis logo
ZoetisZTS

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's effect of exchange rate changes on cash, cash equivalents and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's effect of exchange rate changes on cash, cash equivalents and restricted cash?
Revvity (RVTY) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$7.63M in Q1 2026.
How has Revvity's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
Revvity's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 147.3% year-over-year, from $16.12M to -$7.63M.